Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano-Ditech is a private U.S.-based in vitro diagnostics company focused on rapid immuno-diagnostic products for the point-of-care testing market. The company develops and manufactures lateral flow and related rapid assay products used by medical professionals, clinical laboratories, and hospitals, with a portfolio spanning respiratory infectious disease, cardiac markers, inflammation, and toxicology screening. Its branded products include Nano-Check tests and associated reader-based offerings, and several products have received U.S. FDA 510(k) clearance and, in some cases, CLIA waiver authorization. Nano-Ditech operates from Cranbury, New Jersey and appears to function as a U.S. subsidiary/manufacturing arm associated with South Korea's Precision Biosensor. For a biotech or diagnostics analyst, Nano-Ditech is best understood as a commercial-stage POCT diagnostics manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano-Ditech.